Find a Doctor
Susan Criswell, MD, MSCI, is a neurologist in the Muhammad Ali Parkinson Center, the Lonnie and Muhammad Ali Chair for Movement Disorders Research, and is the Lonnie and Muhammad Ali Professor of Neurology at Barrow Neurological Institute. She is board certified in neurology by the American Board of Psychiatry and Neurology.
Dr. Criswell’s clinical expertise includes the diagnosis and treatment of Parkinson’s disease and other movement disorders. She is a member of the American Academy of Neurology, the American Neurological Association, the Huntington Study Group, the Movement Disorder Society, the Parkinson Study Group, and an elected member of the Executive Committee of the Creighton University School of Medicine.
Dr. Criswell earned her Doctor of Medicine degree from the University of Nebraska Medical Center College of Medicine in Omaha and her Master of Science degree in Clinical Investigation (MSCI) from Washington University in St. Louis, Missouri. She completed her neurology residency and a movement disorders fellowship at Washington University School of Medicine.
Dr. Criswell is a physician-scientist in the Neuroepidemiology Research Program at Barrow. Her research focuses on the molecular, structural, and functional mechanisms of environmental neurotoxicity in Parkinsonian disorders. Dr. Criswell is a world leader in positron emission tomography (PET) to investigate manganese neurotoxicity. She has published her findings in leading clinical neurology and neurotoxicology journals.
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- MSCI, Washington University, 2009
- Fellowship, Washington University School of Medicine, Department of Neurology, Movement Disorders, 2005-2007
- Residency, Washington University School of Medicine, Department of Neurology, 2002-2005
- Internship, Washington University School of Medicine, Department of Medicine, Internal Medicine, 2001-2002
- MD, University of Nebraska Medical Center, College of Medicine, 2001
- American Academy of Neurology
- American Neurological Association
- Huntington Study Group
- Movement Disorder Society
- Parkinson Study Group
- Full Tuition Scholarship, University of Nebraska Medical Center, 2001
- Alpha Omega Alpha, Honor Medical Society, University of Nebraska Medical Center, 2000
- Phi Mu Foundation Scholarship, University of Nebraska Medical Center, 1998-2000
- Reagent Scholarship, University of Nebraska Medical Center, 1998-2000
- Irene and Walter Schormann Trust, University of Nebraska Medical Center, 1997-1998
- McMillen Scholarship, University of Nebraska Medical Center, 1997-1998
Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa.
Date: 07/2024
Authors: K Ray Chaudhuri, Maurizio F Facheris, Bruno Bergmans, Filip Bergquist, S R Criswell, Jia Jia, Pavnit Kukreja, Yohei Mukai, Amy M Spiegel, Resmi Gupta, Lars Bergmann, Rajesh Pahwa
Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with rapid eye movement sleep behavior disorder: a substudy of the North American Prodromal Synucleinopathy Consortium.
Date: 06/2024
Authors: Jonathan E Elliott, Brittany R Ligman, Mohini D Bryant-Ekstrand, Allison T Keil, Katherine Powers, Cosette Olivo, Lee E Neilson, Ronald B Postuma, Amélie Pelletier, Jean-François Gagnon, Ziv Gan-Or, Eric Yu, Lang Liu, Erik K St Louis, Leah K Forsberg, Julie A Fields, Owen A Ross, Daniel E Huddleston, Donald L Bliwise, Alon Y Avidan, Michael J Howell, Carlos H Schenck, Jennifer McLeland, S R Criswell, Aleksandar Videnovic, Emmanuel H During, Mitchell G Miglis, David R Shprecher, Joyce K Lee-Iannotti, Bradley F Boeve, Yo-El S Ju, Miranda M Lim
Olfactory tract/bulb metal concentration in Manganese-exposed mineworkers.
Date: 05/2024
Authors: Luis F Gonzalez-Cuyar, Gill Nelson, Susan Searles Nielsen, Wendy W Dlamini, Amelia Keyser-Gibson, C Dirk Keene, Michael Paulsen, S R Criswell, Natalie Senini, Lianne Sheppard, Shar Samy, Christopher D Simpson, Marissa G Baker, Brad A Racette
Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium.
Date: 02/2024
Authors: Parichita Choudhury, Joyce K Lee-Iannotti, Andrea O Busicescu, Pooja Rangan, Maria Livia Fantini, Alon Y Avidan, Donald L Bliwise, S R Criswell, Emmanuel H During, Jonathan E Elliott, Julie A Fields, Jean-Francois Gagnon, Michael J Howell, Daniel E Huddleston, Jennifer McLeland, Emmanuel Mignot, Mitchell G Miglis, Miranda M Lim, Amélie Pelletier, Carlos H Schenck, David Shprecher, Erik K St Louis, Aleksandar Videnovic, Yo-El S Ju, Bradley F Boeve, Ronald Postuma
Dark Adaptometry and Optical Coherence Tomography Angiography in Huntington Disease.
Date: 01/2024
Authors: Aaditya Shah, Spencer Fuller, S R Criswell, Rajendra S Apte
- English
- (602) 406-6262
- Fax: (602) 406-6261
Susan Criswell, MD, MSCI, is a neurologist in the Muhammad Ali Parkinson Center, the Lonnie and Muhammad Ali Chair for Movement Disorders Research, and is the Lonnie and Muhammad Ali Professor of Neurology at Barrow Neurological Institute. She is board certified in neurology by the American Board of Psychiatry and Neurology.
Dr. Criswell’s clinical expertise includes the diagnosis and treatment of Parkinson’s disease and other movement disorders. She is a member of the American Academy of Neurology, the American Neurological Association, the Huntington Study Group, the Movement Disorder Society, the Parkinson Study Group, and an elected member of the Executive Committee of the Creighton University School of Medicine.
Dr. Criswell earned her Doctor of Medicine degree from the University of Nebraska Medical Center College of Medicine in Omaha and her Master of Science degree in Clinical Investigation (MSCI) from Washington University in St. Louis, Missouri. She completed her neurology residency and a movement disorders fellowship at Washington University School of Medicine.
Dr. Criswell is a physician-scientist in the Neuroepidemiology Research Program at Barrow. Her research focuses on the molecular, structural, and functional mechanisms of environmental neurotoxicity in Parkinsonian disorders. Dr. Criswell is a world leader in positron emission tomography (PET) to investigate manganese neurotoxicity. She has published her findings in leading clinical neurology and neurotoxicology journals.
- (602) 406-6262
- Fax: (602) 406-6261
- Aetna
- AHCCS (Referral Required)
- Blue Cross Blue Shield
- Blue Cross Blue Shield Third Party
- Cigna
- Commercial Networks
- Government Plans
- Humana
- Market Place Plans (Referral Required)
- Medicare Advantage Plans (Referral Required)
- United Healthcare
- MSCI, Washington University, 2009
- Fellowship, Washington University School of Medicine, Department of Neurology, Movement Disorders, 2005-2007
- Residency, Washington University School of Medicine, Department of Neurology, 2002-2005
- Internship, Washington University School of Medicine, Department of Medicine, Internal Medicine, 2001-2002
- MD, University of Nebraska Medical Center, College of Medicine, 2001
- American Academy of Neurology
- American Neurological Association
- Huntington Study Group
- Movement Disorder Society
- Parkinson Study Group
- Full Tuition Scholarship, University of Nebraska Medical Center, 2001
- Alpha Omega Alpha, Honor Medical Society, University of Nebraska Medical Center, 2000
- Phi Mu Foundation Scholarship, University of Nebraska Medical Center, 1998-2000
- Reagent Scholarship, University of Nebraska Medical Center, 1998-2000
- Irene and Walter Schormann Trust, University of Nebraska Medical Center, 1997-1998
- McMillen Scholarship, University of Nebraska Medical Center, 1997-1998
Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa.
Date: 07/2024
Authors: K Ray Chaudhuri, Maurizio F Facheris, Bruno Bergmans, Filip Bergquist, S R Criswell, Jia Jia, Pavnit Kukreja, Yohei Mukai, Amy M Spiegel, Resmi Gupta, Lars Bergmann, Rajesh Pahwa
Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with rapid eye movement sleep behavior disorder: a substudy of the North American Prodromal Synucleinopathy Consortium.
Date: 06/2024
Authors: Jonathan E Elliott, Brittany R Ligman, Mohini D Bryant-Ekstrand, Allison T Keil, Katherine Powers, Cosette Olivo, Lee E Neilson, Ronald B Postuma, Amélie Pelletier, Jean-François Gagnon, Ziv Gan-Or, Eric Yu, Lang Liu, Erik K St Louis, Leah K Forsberg, Julie A Fields, Owen A Ross, Daniel E Huddleston, Donald L Bliwise, Alon Y Avidan, Michael J Howell, Carlos H Schenck, Jennifer McLeland, S R Criswell, Aleksandar Videnovic, Emmanuel H During, Mitchell G Miglis, David R Shprecher, Joyce K Lee-Iannotti, Bradley F Boeve, Yo-El S Ju, Miranda M Lim
Olfactory tract/bulb metal concentration in Manganese-exposed mineworkers.
Date: 05/2024
Authors: Luis F Gonzalez-Cuyar, Gill Nelson, Susan Searles Nielsen, Wendy W Dlamini, Amelia Keyser-Gibson, C Dirk Keene, Michael Paulsen, S R Criswell, Natalie Senini, Lianne Sheppard, Shar Samy, Christopher D Simpson, Marissa G Baker, Brad A Racette
Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium.
Date: 02/2024
Authors: Parichita Choudhury, Joyce K Lee-Iannotti, Andrea O Busicescu, Pooja Rangan, Maria Livia Fantini, Alon Y Avidan, Donald L Bliwise, S R Criswell, Emmanuel H During, Jonathan E Elliott, Julie A Fields, Jean-Francois Gagnon, Michael J Howell, Daniel E Huddleston, Jennifer McLeland, Emmanuel Mignot, Mitchell G Miglis, Miranda M Lim, Amélie Pelletier, Carlos H Schenck, David Shprecher, Erik K St Louis, Aleksandar Videnovic, Yo-El S Ju, Bradley F Boeve, Ronald Postuma
Dark Adaptometry and Optical Coherence Tomography Angiography in Huntington Disease.
Date: 01/2024
Authors: Aaditya Shah, Spencer Fuller, S R Criswell, Rajendra S Apte
- English